Mitochondria-targeted antioxidant supplementation does not affect muscle soreness or recovery of maximal voluntary isometric contraction force following muscle-damaging exercise in untrained men: a randomized clinical trial
- 1 July 2022
- journal article
- research article
- Published by Canadian Science Publishing in Applied Physiology, Nutrition, and Metabolism
- Vol. 47 (7) , 762-774
Abstract
Unaccustomed exercise causes muscle damage resulting in loss of muscle function, which may be attributable to exercise-induced increases in skeletal muscle reactive oxygen species. This study examined the effect of mitochondria-targeted antioxidant supplementation on recovery of muscle function following exercise. Thirty-two untrained men received MitoQ (20 mg/day) or a placebo for 14 days before performing 300 maximal eccentric contractions of the knee extensor muscles of 1 leg. Muscle function was assessed using isokinetic dynamometry before, immediately after, and 24, 48, 72, and 168 hours after exercise. Muscle soreness was assessed using a visual analogue scale 24, 48, 72, and 168 hours after exercise. Blood samples were collected before, immediately after, and 2, 24, 48, 72, and 168 hours after exercise and urine samples were collected before and during the 48 hours after exercise. The reduction in maximal voluntary isometric contraction force and peak concentric torque following exercise was unaffected by MitoQ while recovery of peak eccentric torque was delayed in the MitoQ group. Exercise-induced increases in urine F2-isoprostanes were unaffected by MitoQ. MitoQ augmented exercise-induced increases in plasma creatine kinase levels, while plasma IL-6 was similar between groups. Muscle soreness was not affected by MitoQ. These results indicate that MitoQ does not attenuate post-exercise muscle soreness and may delay recovery of muscle function following eccentric exercise. Trial registration number: ACTRN12620001089921. Novelty: Post-exercise recovery of maximal voluntary isometric contraction force and peak concentric torque were unaffected by MitoQ. MitoQ delayed post-exercise recovery of peak eccentric torque. Post-exercise muscle soreness was unaffected by MitoQ.Keywords
Funding Information
- Callaghan Innovation Research & Development Grant (APOD1701)
- Rutherford Discovery Fellowship
This publication has 44 references indexed in Scilit:
- No effect of antioxidant supplementation on muscle performance and blood redox status adaptations to eccentric trainingThe American Journal of Clinical Nutrition, 2011
- Redox compartmentalization and cellular stressDiabetes, Obesity and Metabolism, 2010
- Exercise-induced brachial artery vasodilation: effects of antioxidants and exercise training in elderly menAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Does Antioxidant Vitamin Supplementation Protect against Muscle Damage?Sports Medicine, 2009
- Antioxidants prevent health-promoting effects of physical exercise in humansProceedings of the National Academy of Sciences of the United States of America, 2009
- Redox compartmentalization in eukaryotic cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Exercise, MAPK, and NF-κB signaling in skeletal muscleJournal of Applied Physiology, 2007
- Ascorbic acid supplementation does not attenuate post-exercise muscle soreness following muscle-damaging exercise but may delay the recovery processBritish Journal of Nutrition, 2006
- Exercise-Induced Muscle Damage in HumansAmerican Journal of Physical Medicine & Rehabilitation, 2002
- Delayed‐onset muscle damage and lipid peroxidation in man after a downhill runMuscle & Nerve, 1989